Uses
Dextrose and Sodium Chloride Injection is indicated as a source of water, electrolytes and calories.
Source: US FDA prescribing information
Fixed-dose combination
Dextrose and Sodium chloride
Also known as dextrose monohydrate, sodium chloride
Available on request
- Presentations
- 14
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Dextrose and Sodium chloride is a fixed-dose combination medicine indicated as a source of water, electrolytes and calories. It is available as injection for intravenous use. MedsAcross supplies Dextrose and Sodium chloride for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- Pharmacological class
- Osmotic Laxative, Osmotic Activity, Increased Large Intestinal Motility, Inhibition Large Intestine Fluid/Electrolyte Absorption
- US FDA first approval
- 8 December 1970
- EU status
- Not recorded
- Orphan designation
- Not recorded
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Routes
- Intravenous
- Dosage forms
- Injection
- Fixed-dose combination of
- Dextrose, Sodium chloride
Clinical information
From the regulator-approved product information. Each section names its source.
How it works
Dextrose and Sodium Chloride Injection is a source of water, electrolytes and calories. It is capable of inducing diuresis depending on the clinical condition of the patient.
Source: US FDA prescribing information
Dosing overview
• Only for intravenous infusion. • See full prescribing information for information on preparation, administration, dosing considerations and instructions for use.
Source: US FDA prescribing information
Contraindications
Dextrose and Sodium Chloride Injection is contraindicated in patients with: • known hypersensitivity to dextrose and/or sodium chloride • clinically significant hyperglycemia • Known hypersensitivity to dextrose, or sodium chloride. • Clinically significant hyperglycemia
Source: US FDA prescribing information
Warnings and precautions
• Hypersensitivity Reactions: Monitor for signs and symptoms and discontinue infusion if reactions occur. • Hyperglycemia or Hyperosmolar Hyperglycemic State: Monitor blood glucose and administer insulin as needed. • Hyponatremia, Hypokalemia, Hypernatremia and Hyperchloremia: Avoid in patients with or at risk for hypo-/hypernatremia and hypokalemia. If use cannot be avoided, monitor serum sodium and potassium concentrations. • Fluid Overload: Avoid in patients with or at risk for fluid and/or solute overloading. If use cannot be avoided, monitor daily fluid balance and electrolyte, concentrations and acid-base balance, as needed and especially during prolonged use. • Refeeding Syndrome: Monitor severely undernourished patients and slowly increase nutrient intake.
Source: US FDA prescribing information
Side effects
- Anaphylactic reaction, hypersensitivity, and chills - Hyponatremia (applies to solutions containing less than 0.9% Sodium Chloride) Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary. Adverse reactions include electrolyte imbalances, hyperglycemia, and hypervolemia and injection site reactions.
Source: US FDA prescribing information
Interactions
• Other Products that Affect Glycemic Control, Vasopressin or Fluid and/or Electrolyte Balance: Monitor blood glucose concentrations, fluid balance serum electrolyte concentrations and acid-base balance. • Lithium: Decreased lithium concentrations with concomitant use, monitor serum lithium concentrations.
Source: US FDA prescribing information
Storage
Store at room temperature (25°C/77°F), brief exposure up to 40°C/104°F does not adversely affect the product.
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
All presentations
14 presentations of Dextrose and Sodium chloride, sorted by availability.
| Medicine | Active ingredient | Manufacturer | Register | Availability |
|---|---|---|---|---|
| Dextrose and Sodium chloride 25 g/2.25 g per 500 mL injectionIntravenousGeneric name | Dextrose and Sodium chloride | — | US FDA | Available on request |
| Dextrose and Sodium chloride 25 g/4.5 g per 500 mL injectionIntravenousGeneric name | Dextrose and Sodium chloride | — | US FDA | Available on request |
| Dextrose and Sodium chloride 50 g/4.5 g per 1000 mL injectionIntravenousGeneric name | Dextrose and Sodium chloride | — | US FDA | Available on request |
| Dextrose and Sodium chloride 50 g/9 g per 1000 mL injectionIntravenousGeneric name | Dextrose and Sodium chloride | — | US FDA | Available on request |
| Dextrose and Sodium chloride 12.5 g/1.125 g per 250 mL injectionIntravenousGeneric name | Dextrose and Sodium chloride | — | US FDA | Available on request |
| Dextrose and Sodium chloride 12.5 g/0.5625 g per 250 mL injectionIntravenousGeneric name | Dextrose and Sodium chloride | — | US FDA | Available on request |
| Dextrose and Sodium chloride 25 g/1.125 g per 500 mL injectionIntravenousGeneric name | Dextrose and Sodium chloride | — | US FDA | Available on request |
| Dextrose and Sodium chloride 25 g/1.5 g per 500 mL injectionIntravenousGeneric name | Dextrose and Sodium chloride | — | US FDA | Available on request |
| Dextrose and Sodium chloride 25 g/4.5 g per 1000 mL injectionIntravenousGeneric name | Dextrose and Sodium chloride | — | US FDA | Available on request |
| Dextrose and Sodium chloride 50 g/2.25 g per 1000 mL injectionIntravenousGeneric name | Dextrose and Sodium chloride | — | US FDA | Available on request |
| Dextrose and Sodium chloride 50 g/3 g per 1000 mL injectionIntravenousGeneric name | Dextrose and Sodium chloride | — | US FDA | Available on request |
| Dextrose and Sodium chloride 12.5 g/0.75 g per 250 mL injectionIntravenousGeneric name | Dextrose and Sodium chloride | — | US FDA | Available on request |
| Dextrose and Sodium chloride 12.5 g/500 mg per 250 mL injectionIntravenousGeneric name | Dextrose and Sodium chloride | — | US FDA | Available on request |
| Dextrose and Sodium chloride 50 g/2000 mg per 1000 mL injectionIntravenousGeneric name | Dextrose and Sodium chloride | — | US FDA | Available on request |
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | First approved 8 December 1970 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Questions and answers
Is Dextrose and Sodium chloride available for export from India?
Yes, on request. MedsAcross lists 14 presentations of Dextrose and Sodium chloride and sources them for licensed hospitals, importers and physicians against valid import documents.
Is Dextrose and Sodium chloride approved by the US FDA?
Yes. The US FDA first approved Dextrose and Sodium chloride on 8 December 1970, according to Drugs@FDA.
Does Dextrose and Sodium chloride need cold chain shipping?
No listed presentation of Dextrose and Sodium chloride is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
References
- Dextrose and Sodium Chloride prescribing information (Baxter Healthcare). U.S. National Library of Medicine, DailyMed. Retrieved 26 August 2025
Request Dextrose and Sodium chloride for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.